Broncho-munal p capsules 3.5 mg №30

Dosage form

capsules

Composition

1 capsule contains:

- Lyophilized lysate of bacteria - 3.5 mg, most often causing respiratory tract infections: Streptococcus pneumoniae, anemia, Haemophilus influenzae, Klebsiella pneumoniae, Klebsiella ozaenae, Staphylococcus aureus, Streptococcus viridans, Streptococcus pyogenes, Moraxelaus, Streptococcus viridans, Streptococcus pyogenes, Moraxella aureus, Streptococcus viridans, Streptococcus pyrogenes, Moraxella aureus
- Auxiliary components: propyl gallate, mannitol, sodium glutamate anhydrous, Magnesium stearate, corn starch.

Packing

In the blister 30 capsules of 3.5 mg. In a pack of cardboard 1 blister.

Mechanism of action

Broncho-munal is an immunomodulatory drug of bacterial origin.

Stimulates both the local cellular and humoral immune response in the mucous membrane of the respiratory tract and the systemic immune response. The drug stimulates the activity of alveolar macrophages, increases the number and activity of T-lymphocytes, activates peripheral monocytes, increases the concentration of secretory IgA on the mucous membranes of the respiratory tract and digestive tract, stimulates the production of protective adhesive molecules, reduces the concentration of IgE antibodies in the blood, also increases the production of cytokines.

Reduces the frequency and severity of infections, thereby reducing the need for antibiotics.

Indications and usage

For prophylaxis and as part of combination therapy of infectious and inflammatory diseases of the respiratory tract:

- Chronical bronchitis.
- Tonsillitis, pharyngitis, laryngitis.
- Rhinitis, sinusitis, otitis media.

Contraindications

Hypersensitivity to the drug.

Pregnancy and Breastfeeding

The safety of the use of the drug Broncho-Munal during pregnancy and during breastfeeding has not been studied, so the use of the drug during these periods is not recommended.

It is not known whether the drug is excreted in breast milk.

Dosage and administration

Adults and children over 12 years old are prescribed Broncho-munal in a dose of 7 mg.

Children between the ages of 6 months and 12 years are prescribed Bronchounal P at a dose of 3.5 mg.

The drug is taken in the morning on an empty stomach for 1 caps / day.

If the child cannot swallow the capsule, it is recommended to open it, and dissolve the contents of the capsule in a small amount of liquid (tea, milk or juice).

- In the acute period of the disease - 1 caps. for 10 days, if necessary, along with antibiotics. The next 2 months. - 1 caps. for 10 days, maintaining a 20-day interval.
- For prevention - 1 caps. per day for 10 days (3 courses) with 20-day intervals between them (it is desirable to begin therapy every month on the same day).

Adverse reactions

During the entire period of clinical use of the drug, undesirable effects were recorded extremely rarely.

- On the part of the gastrointestinal tract: stomach pain, nausea, vomiting, diarrhea (extremely rare).
- Other: fever, rarely - the development of hypersensitivity reactions (skin rash).

Special notes

A 4-week interval is recommended between drug intake and oral vaccines.

You should not prescribe the drug for acute intestinal diseases (decreases the effectiveness of the drug).

If side effects are mild, drug withdrawal is not required. When a hypersensitivity reaction occurs, drug withdrawal is recommended.

- Use in pediatrics The drug is not prescribed to children under the age of 6 months. In order to avoid overdosing, children are prescribed only Broncho-Munal P (capsules containing 3.5 mg of lyophilisate).

Overdosage

Currently, cases of overdose of the drug Broncho-Munal were reported.

Storage conditions

- In a dry place at a temperature not higher than 25 ° C.

5 years.